Madison Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$557K Hold
4,000
0.01% 317
2025
Q4
$491K Hold
4,000
0.01% 316
2025
Q3
$444K Hold
4,000
﹤0.01% 310
2025
Q2
$443K Sell
4,000
-800
-17% -$85.1K ﹤0.01% 304
2025
Q1
$538K Buy
4,800
+800
+20% +$82.5K 0.01% 292
2024
Q4
$369K Hold
4,000
﹤0.01% 312
2024
Q3
$335K Sell
4,000
-27,680
-87% -$2.11M ﹤0.01% 306
2024
Q2
$2.17M Hold
31,680
0.03% 250
2024
Q1
$2.32M Sell
31,680
-24,219
-43% -$1.86M 0.03% 243
2023
Q4
$4.53M Buy
55,899
+8,010
+17% +$623K 0.06% 183
2023
Q3
$3.59M Buy
47,889
+43,635
+1,026% +$3.36M 0.05% 196
2023
Q2
$328K Sell
4,254
-3,470
-45% -$277K ﹤0.01% 303
2023
Q1
$641K Sell
7,724
-2,405
-24% -$199K 0.01% 271
2022
Q4
$870K Sell
10,129
-111,483
-92% -$8.83M 0.01% 275
2022
Q3
$7.5M Sell
121,612
-125
-0.1% -$7.88K 0.13% 128
2022
Q2
$7.53M Buy
121,737
+7,413
+6% +$459K 0.12% 136
2022
Q1
$6.8M Sell
114,324
-690
-0.6% -$44.1K 0.1% 138
2021
Q4
$8.35M Sell
115,014
-6,005
-5% -$414K 0.11% 134
2021
Q3
$8.45M Sell
121,019
-81
-0.1% -$5.69K 0.12% 137
2021
Q2
$8.34M Buy
121,100
+23,965
+25% +$1.6M 0.11% 139
2021
Q1
$6.28M Hold
97,135
0.09% 163
2020
Q4
$5.66M Sell
97,135
-484
-0.5% -$29.2K 0.08% 167
2020
Q3
$6.17M Sell
97,619
-115,255
-54% -$7.99M 0.1% 140
2020
Q2
$16.4M Buy
212,874
+47,858
+29% +$3.67M 0.29% 98
2020
Q1
$12.3M Buy
165,016
+92,416
+127% +$6.39M 0.25% 102
2019
Q4
$4.72M Buy
+72,600
New +$4.73M 0.07% 197

Other funds holding GILD

Madison Asset Management's GILD Position: Q1 2026 in Review

Madison Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 4,000 shares worth $557K. The position accounts for 0.01% of the portfolio, ranked #317.

Madison Asset Management first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $16.4M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Madison Asset Management held 4,000 shares of Gilead Sciences worth $557K as of Q1 2026.
  • Madison Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Madison Asset Management's portfolio in Q1 2026, its #317 holding.
  • Madison Asset Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • Madison Asset Management's Gilead Sciences position peaked at $16.4M in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.